25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ATH (Alterity Therapeutics Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Alterity Therapeutics Ltd together

I guess you are interested in Alterity Therapeutics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Alterity Therapeutics Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Alterity Therapeutics Ltd’s Price Targets

I'm going to help you getting a better view of Alterity Therapeutics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Alterity Therapeutics Ltd

I send you an email if I find something interesting about Alterity Therapeutics Ltd.

1. Quick Overview

1.1. Quick analysis of Alterity Therapeutics Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Alterity Therapeutics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.01
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.01
Return On Investment
95.6%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0.009 - A$0.012
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Alterity Therapeutics Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.01
Intrinsic Value Per Share
A$-0.01 - A$-0.01
Total Value Per Share
A$-0.01 - A$0.00

2.2. Growth of Alterity Therapeutics Ltd (5 min.)




Is Alterity Therapeutics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$27.6m$8.9m$18.6m67.5%

How much money is Alterity Therapeutics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$7.9m-$12.4m$4.5m57.4%
Net Profit Margin-223.4%-475.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Alterity Therapeutics Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#459 / 848

Most Revenue
#377 / 848

Most Profit
#490 / 848

Most Efficient
#517 / 848
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Alterity Therapeutics Ltd?

Welcome investor! Alterity Therapeutics Ltd's management wants to use your money to grow the business. In return you get a share of Alterity Therapeutics Ltd.

First you should know what it really means to hold a share of Alterity Therapeutics Ltd. And how you can make/lose money.

Speculation

The Price per Share of Alterity Therapeutics Ltd is A$0.011. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alterity Therapeutics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alterity Therapeutics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alterity Therapeutics Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-6.6%0.00-6.6%0.00-10.4%0.00-8.2%0.00-8.0%0.00-6.7%
Usd Book Value Change Per Share0.0015.6%0.0015.6%0.00-4.9%0.001.3%0.003.5%0.000.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.0015.6%0.0015.6%0.00-4.9%0.001.3%0.003.5%0.000.2%
Usd Price Per Share0.01-0.01-0.00-0.00-0.01-0.02-
Price to Earnings Ratio-8.95--8.95--2.27--5.58--9.53--35.91-
Price-to-Total Gains Ratio3.80-3.80--4.83--2.35-7.31-39.61-
Price to Book Ratio2.56-2.56-3.15-3.02-4.61-14.75-
Price-to-Total Gains Ratio3.80-3.80--4.83--2.35-7.31-39.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0071676
Number of shares139516
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (139516 shares)239.1153.26
Gains per Year (139516 shares)956.45213.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
109569460213203
20191319020426416
30286928580639629
40382638140852842
5047824770010651055
6057395726012781268
7066956682014911481
8076527638017041694
9086088594019171907
10095649550021302120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.024.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%12.012.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.024.00.0%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%3.02.00.060.0%4.06.00.040.0%12.012.00.050.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Alterity Therapeutics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0030.0030%-0.001+132%0.000+1138%0.001+349%0.000+8595%
Book Value Per Share--0.0040.0040%0.001+207%0.002+61%0.003+46%0.002+74%
Current Ratio--12.97712.9770%3.543+266%7.564+72%8.136+60%8.874+46%
Debt To Asset Ratio--0.0790.0790%0.282-72%0.175-55%0.152-48%0.141-44%
Debt To Equity Ratio--0.0850.0850%0.393-78%0.225-62%0.189-55%0.172-50%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--145789531.290145789531.2900%50714864.316+187%94633788.636+54%156741287.280-7%348134049.669-58%
Eps---0.001-0.0010%-0.002+57%-0.001+24%-0.001+21%-0.001+1%
Ev To Ebitda Ratio---9.963-9.9630%-2.210-78%-5.721-43%-8.795-12%-34.094+242%
Ev To Sales Ratio--26.80526.8050%12.618+112%20.580+30%34.182-22%2894.535-99%
Free Cash Flow Per Share---0.001-0.0010%-0.001+10%-0.001+28%-0.001+29%-0.001+2%
Free Cash Flow To Equity Per Share--0.0030.0030%0.000+112%0.000+1626%0.001+402%0.000+16636%
Gross Profit Margin--1.0001.0000%1.0010%1.0010%1.0020%1.0010%
Intrinsic Value_10Y_max---0.008----------
Intrinsic Value_10Y_min---0.011----------
Intrinsic Value_1Y_max---0.001----------
Intrinsic Value_1Y_min---0.001----------
Intrinsic Value_3Y_max---0.003----------
Intrinsic Value_3Y_min---0.004----------
Intrinsic Value_5Y_max---0.005----------
Intrinsic Value_5Y_min---0.006----------
Market Cap119629579.619+9%108754163.290108754163.2900%43501665.316+150%76127914.303+43%134855162.480-19%329525114.769-67%
Net Profit Margin---2.234-2.2340%-4.758+113%-3.506+57%-3.310+48%-86.660+3780%
Operating Margin---2.696-2.6960%-5.746+113%-4.313+60%-4.165+55%-109.354+3957%
Operating Ratio--3.6803.6800%5.877-37%4.762-23%4.562-19%89.895-96%
Pb Ratio2.821+9%2.5652.5650%3.153-19%3.018-15%4.607-44%14.745-83%
Pe Ratio-9.848-10%-8.953-8.9530%-2.275-75%-5.580-38%-9.527+6%-35.907+301%
Price Per Share0.011+9%0.0100.0100%0.004+150%0.007+43%0.012-19%0.030-67%
Price To Free Cash Flow Ratio-10.447-10%-9.497-9.4970%-3.449-64%-5.582-41%-9.137-4%-40.438+326%
Price To Total Gains Ratio4.182+9%3.8023.8020%-4.826+227%-2.346+162%7.306-48%39.613-90%
Quick Ratio--14.73814.7380%3.104+375%7.805+89%8.142+81%8.801+67%
Return On Assets---0.264-0.2640%-0.995+277%-0.588+123%-0.506+92%-0.486+84%
Return On Equity---0.286-0.2860%-1.386+384%-0.759+165%-0.628+119%-0.590+106%
Total Gains Per Share--0.0030.0030%-0.001+132%0.000+1138%0.001+349%0.000+8595%
Usd Book Value--27629850.83827629850.8380%8990813.941+207%17161852.094+61%18890288.383+46%15846534.724+74%
Usd Book Value Change Per Share--0.0020.0020%-0.001+132%0.000+1138%0.000+349%0.000+8595%
Usd Book Value Per Share--0.0030.0030%0.001+207%0.002+61%0.002+46%0.001+74%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--94996458.58994996458.5890%33045805.588+187%61663376.675+54%102132622.791-7%226844146.764-58%
Usd Eps---0.001-0.0010%-0.001+57%-0.001+24%-0.001+21%-0.001+1%
Usd Free Cash Flow---7461633.197-7461633.1970%-8217683.374+10%-9579810.602+28%-9627116.849+29%-7617466.855+2%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.001+10%-0.001+28%-0.001+29%-0.001+2%
Usd Free Cash Flow To Equity Per Share--0.0020.0020%0.000+112%0.000+1626%0.000+402%0.000+16636%
Usd Market Cap77950634.080+9%70864212.80070864212.8000%28345685.120+150%49604948.960+43%87871623.872-19%214718564.783-67%
Usd Price Per Share0.007+9%0.0070.0070%0.003+150%0.005+43%0.008-19%0.020-67%
Usd Profit---7915524.725-7915524.7250%-12460849.142+57%-9790899.680+24%-9543883.681+21%-7740556.311-2%
Usd Revenue--3543998.9693543998.9690%2618966.106+35%2904949.219+22%2976203.851+19%1527320.752+132%
Usd Total Gains Per Share--0.0020.0020%-0.001+132%0.000+1138%0.000+349%0.000+8595%
 EOD+6 -2MRQTTM+0 -0YOY+35 -33Y+35 -35Y+28 -1010Y+27 -11

3.3 Fundamental Score

Let's check the fundamental score of Alterity Therapeutics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.848
Price to Book Ratio (EOD)Between0-12.821
Net Profit Margin (MRQ)Greater than0-2.234
Operating Margin (MRQ)Greater than0-2.696
Quick Ratio (MRQ)Greater than114.738
Current Ratio (MRQ)Greater than112.977
Debt to Asset Ratio (MRQ)Less than10.079
Debt to Equity Ratio (MRQ)Less than10.085
Return on Equity (MRQ)Greater than0.15-0.286
Return on Assets (MRQ)Greater than0.05-0.264
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Alterity Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.012
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Alterity Therapeutics Ltd

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434, a small molecule drug candidate that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; and ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy, as well as biomarkers of progression in multiple system atrophy. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2025-10-18 22:00:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Alterity Therapeutics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -223.4% means that $-2.23 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alterity Therapeutics Ltd:

  • The MRQ is -223.4%. The company is making a huge loss. -2
  • The TTM is -223.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-223.4%TTM-223.4%0.0%
TTM-223.4%YOY-475.8%+252.4%
TTM-223.4%5Y-331.0%+107.7%
5Y-331.0%10Y-8,666.0%+8,334.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-223.4%-77.6%-145.8%
TTM-223.4%-167.4%-56.0%
YOY-475.8%-186.6%-289.2%
3Y-350.6%-264.1%-86.5%
5Y-331.0%-344.5%+13.5%
10Y-8,666.0%-475.7%-8,190.3%
4.3.1.2. Return on Assets

Shows how efficient Alterity Therapeutics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • -26.4% Return on Assets means that Alterity Therapeutics Ltd generated $-0.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alterity Therapeutics Ltd:

  • The MRQ is -26.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -26.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.4%TTM-26.4%0.0%
TTM-26.4%YOY-99.5%+73.1%
TTM-26.4%5Y-50.6%+24.2%
5Y-50.6%10Y-48.6%-2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.4%-11.9%-14.5%
TTM-26.4%-11.8%-14.6%
YOY-99.5%-11.0%-88.5%
3Y-58.8%-12.0%-46.8%
5Y-50.6%-11.7%-38.9%
10Y-48.6%-13.8%-34.8%
4.3.1.3. Return on Equity

Shows how efficient Alterity Therapeutics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • -28.6% Return on Equity means Alterity Therapeutics Ltd generated $-0.29 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alterity Therapeutics Ltd:

  • The MRQ is -28.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-28.6%TTM-28.6%0.0%
TTM-28.6%YOY-138.6%+109.9%
TTM-28.6%5Y-62.8%+34.2%
5Y-62.8%10Y-59.0%-3.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.6%-14.2%-14.4%
TTM-28.6%-14.8%-13.8%
YOY-138.6%-15.0%-123.6%
3Y-75.9%-16.6%-59.3%
5Y-62.8%-16.8%-46.0%
10Y-59.0%-19.5%-39.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Alterity Therapeutics Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Alterity Therapeutics Ltd is operating .

  • Measures how much profit Alterity Therapeutics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • An Operating Margin of -269.6% means the company generated $-2.70  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alterity Therapeutics Ltd:

  • The MRQ is -269.6%. The company is operating very inefficient. -2
  • The TTM is -269.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-269.6%TTM-269.6%0.0%
TTM-269.6%YOY-574.6%+305.1%
TTM-269.6%5Y-416.5%+146.9%
5Y-416.5%10Y-10,935.4%+10,518.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-269.6%-155.0%-114.6%
TTM-269.6%-266.6%-3.0%
YOY-574.6%-247.8%-326.8%
3Y-431.3%-250.4%-180.9%
5Y-416.5%-345.8%-70.7%
10Y-10,935.4%-503.1%-10,432.3%
4.3.2.2. Operating Ratio

Measures how efficient Alterity Therapeutics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 3.68 means that the operating costs are $3.68 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 3.680. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.680. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ3.680TTM3.6800.000
TTM3.680YOY5.877-2.197
TTM3.6805Y4.562-0.882
5Y4.56210Y89.895-85.333
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6801.882+1.798
TTM3.6802.793+0.887
YOY5.8772.810+3.067
3Y4.7623.587+1.175
5Y4.5624.650-0.088
10Y89.8956.271+83.624
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Alterity Therapeutics Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Alterity Therapeutics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 12.98 means the company has $12.98 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 12.977. The company is very able to pay all its short-term debts. +2
  • The TTM is 12.977. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.977TTM12.9770.000
TTM12.977YOY3.543+9.435
TTM12.9775Y8.136+4.842
5Y8.13610Y8.874-0.739
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.9773.414+9.563
TTM12.9773.623+9.354
YOY3.5434.035-0.492
3Y7.5644.425+3.139
5Y8.1365.714+2.422
10Y8.8746.116+2.758
4.4.3.2. Quick Ratio

Measures if Alterity Therapeutics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 14.74 means the company can pay off $14.74 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 14.738. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 14.738. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ14.738TTM14.7380.000
TTM14.738YOY3.104+11.634
TTM14.7385Y8.142+6.597
5Y8.14210Y8.801-0.659
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.7382.912+11.826
TTM14.7383.149+11.589
YOY3.1043.831-0.727
3Y7.8054.379+3.426
5Y8.1425.697+2.445
10Y8.8016.523+2.278
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Alterity Therapeutics Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Alterity Therapeutics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alterity Therapeutics Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Alterity Therapeutics Ltd assets are financed with 7.9% credit (debt) and the remaining percentage (100% - 7.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.079. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.079. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.079TTM0.0790.000
TTM0.079YOY0.282-0.204
TTM0.0795Y0.152-0.074
5Y0.15210Y0.141+0.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0790.342-0.263
TTM0.0790.359-0.280
YOY0.2820.329-0.047
3Y0.1750.344-0.169
5Y0.1520.348-0.196
10Y0.1410.378-0.237
4.5.4.2. Debt to Equity Ratio

Measures if Alterity Therapeutics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.5% means that company has $0.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alterity Therapeutics Ltd:

  • The MRQ is 0.085. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.085. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.085TTM0.0850.000
TTM0.085YOY0.393-0.308
TTM0.0855Y0.189-0.103
5Y0.18910Y0.172+0.017
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0850.400-0.315
TTM0.0850.439-0.354
YOY0.3930.431-0.038
3Y0.2250.470-0.245
5Y0.1890.467-0.278
10Y0.1720.517-0.345
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Alterity Therapeutics Ltd generates.

  • Above 15 is considered overpriced but always compare Alterity Therapeutics Ltd to the Biotechnology industry mean.
  • A PE ratio of -8.95 means the investor is paying $-8.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is -9.848. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.953. Based on the earnings, the company is expensive. -2
  • The TTM is -8.953. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.848MRQ-8.953-0.895
MRQ-8.953TTM-8.9530.000
TTM-8.953YOY-2.275-6.678
TTM-8.9535Y-9.527+0.575
5Y-9.52710Y-35.907+26.380
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.848-2.920-6.928
MRQ-8.953-2.294-6.659
TTM-8.953-2.690-6.263
YOY-2.275-3.622+1.347
3Y-5.580-3.859-1.721
5Y-9.527-5.932-3.595
10Y-35.907-6.948-28.959
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is -10.447. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.497. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.497. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.447MRQ-9.497-0.950
MRQ-9.497TTM-9.4970.000
TTM-9.497YOY-3.449-6.048
TTM-9.4975Y-9.137-0.361
5Y-9.13710Y-40.438+31.301
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.447-3.683-6.764
MRQ-9.497-2.922-6.575
TTM-9.497-3.871-5.626
YOY-3.449-4.346+0.897
3Y-5.582-5.307-0.275
5Y-9.137-8.378-0.759
10Y-40.438-9.842-30.596
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Alterity Therapeutics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.56 means the investor is paying $2.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Alterity Therapeutics Ltd:

  • The EOD is 2.821. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.565. Based on the equity, the company is underpriced. +1
  • The TTM is 2.565. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.821MRQ2.565+0.256
MRQ2.565TTM2.5650.000
TTM2.565YOY3.153-0.588
TTM2.5655Y4.607-2.042
5Y4.60710Y14.745-10.139
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.8212.524+0.297
MRQ2.5652.071+0.494
TTM2.5652.250+0.315
YOY3.1532.465+0.688
3Y3.0182.698+0.320
5Y4.6073.840+0.767
10Y14.7454.569+10.176
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Alterity Therapeutics Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets46,026
Total Liabilities3,623
Total Stockholder Equity42,403
 As reported
Total Liabilities 3,623
Total Stockholder Equity+ 42,403
Total Assets = 46,026

Assets

Total Assets46,026
Total Current Assets45,871
Long-term Assets155
Total Current Assets
Cash And Cash Equivalents 33,159
Short-term Investments 7,500
Net Receivables 3,938
Other Current Assets 1,275
Total Current Assets  (as reported)45,871
Total Current Assets  (calculated)45,871
+/-0
Long-term Assets
Property Plant Equipment 155
Long-term Assets  (as reported)155
Long-term Assets  (calculated)155
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,535
Long-term Liabilities89
Total Stockholder Equity42,403
Total Current Liabilities
Short-term Debt 134
Accounts payable 538
Other Current Liabilities 2,846
Total Current Liabilities  (as reported)3,535
Total Current Liabilities  (calculated)3,518
+/- 16
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt22
Long-term Liabilities  (as reported)89
Long-term Liabilities  (calculated)22
+/- 67
Total Stockholder Equity
Common Stock262,949
Retained Earnings -225,889
Accumulated Other Comprehensive Income 5,342
Total Stockholder Equity (as reported)42,403
Total Stockholder Equity (calculated)42,403
+/-0
Other
Capital Stock262,949
Cash and Short Term Investments 40,659
Common Stock Shares Outstanding 6,396,924
Liabilities and Stockholders Equity 46,026
Net Debt -33,003
Net Invested Capital 42,403
Net Working Capital 42,336
Property Plant and Equipment Gross 155
Short Long Term Debt Total 155



5.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-302001-06-302000-06-301999-06-301998-06-30
> Total Assets 
199
1,837
20,876
22,287
17,591
16,341
41,164
22,199
10,427
7,721
11,723
4,597
6,801
9,011
7,342
17,074
41,641
41,834
33,725
25,281
18,726
19,910
13,305
33,586
41,363
27,318
19,224
46,026
46,02619,22427,31841,36333,58613,30519,91018,72625,28133,72541,83441,64117,0747,3429,0116,8014,59711,7237,72110,42722,19941,16416,34117,59122,28720,8761,837199
   > Total Current Assets 
0
0
4,470
6,855
3,755
3,649
29,565
22,033
10,325
7,673
11,619
4,491
6,708
8,932
7,256
16,983
41,549
41,744
33,657
25,250
18,655
19,861
13,233
33,489
41,144
27,049
19,037
45,871
45,87119,03727,04941,14433,48913,23319,86118,65525,25033,65741,74441,54916,9837,2568,9326,7084,49111,6197,67310,32522,03329,5653,6493,7556,8554,47000
       Cash And Cash Equivalents 
0
0
4,470
6,855
3,587
3,454
29,401
21,366
10,020
7,408
11,243
4,305
5,227
8,838
5,636
13,347
34,167
34,910
28,594
21,885
15,236
14,400
9,197
28,116
34,807
15,774
12,639
33,159
33,15912,63915,77434,80728,1169,19714,40015,23621,88528,59434,91034,16713,3475,6368,8385,2274,30511,2437,40810,02021,36629,4013,4543,5876,8554,47000
       Short-term Investments 
0
0
0
0
0
0
0
0
42
46
0
0
0
0
0
0
0
153
0
44
10
0
0
0
0
0
0
7,500
7,500000000104401530000000464200000000
       Net Receivables 
0
0
0
0
108
143
92
126
75
70
31
1
1,407
7
1,552
3,526
34
6,522
4,787
3,036
3,152
4,829
3,458
4,126
4,669
8,649
4,042
3,938
3,9384,0428,6494,6694,1263,4584,8293,1523,0364,7876,522343,5261,55271,4071317075126921431080000
       Other Current Assets 
0
0
0
0
60
52
72
541
230
149
344
185
74
87
67
110
202
160
277
286
257
632
10
1,247
1,668
2,626
2,356
1,275
1,2752,3562,6261,6681,247106322572862771602021106787741853441492305417252600000
   > Long-term Assets 
0
0
0
0
13,835
12,692
11,598
166
102
48
105
106
94
79
86
91
92
90
68
31
71
49
71
97
219
269
187
155
1551872692199771497131689092918679941061054810216611,59812,69213,8350000
       Property Plant Equipment 
0
0
0
0
140
141
180
166
102
48
69
71
59
41
38
47
48
45
24
31
71
49
71
97
219
269
187
155
1551872692199771497131244548473841597169481021661801411400000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44
0
0
0
0
0
0
0
0
0
00000000044000000000000000000
       Intangible Assets 
0
0
0
0
13,696
12,551
11,419
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000011,41912,55113,6960000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
35
35
35
38
10
44
0
0
44
-31
-71
-49
-71
-97
-219
-269
0
0
00-269-219-97-71-49-71-3144004410383535350000000000
> Total Liabilities 
200
1,918
147
895
913
565
2,696
2,684
1,693
2,110
1,836
847
1,572
2,080
1,718
3,099
3,955
2,721
2,358
1,591
2,645
3,355
2,757
3,115
5,894
4,505
5,426
3,623
3,6235,4264,5055,8943,1152,7573,3552,6451,5912,3582,7213,9553,0991,7182,0801,5728471,8362,1101,6932,6842,6965659138951471,918200
   > Total Current Liabilities 
0
0
0
0
913
563
2,688
2,639
1,616
1,739
972
799
1,500
2,075
1,711
3,099
3,952
2,719
2,357
1,590
2,644
3,320
2,715
3,068
5,820
4,382
5,374
3,535
3,5355,3744,3825,8203,0682,7153,3202,6441,5902,3572,7193,9523,0991,7112,0751,5007999721,7391,6162,6392,6885639130000
       Short-term Debt 
0
0
0
0
0
0
0
0
42
46
0
0
0
290
299
803
0
153
0
44
10
33
33
55
58
214
214
134
13421421458553333104401530803299290000464200000000
       Accounts payable 
0
0
0
0
843
540
2,646
2,561
953
460
172
110
1,244
311
202
279
651
362
312
65
1,334
1,694
954
1,449
2,662
1,716
581
538
5385811,7162,6621,4499541,6941,334653123626512792023111,2441101724609532,5612,6465408430000
       Other Current Liabilities 
0
0
0
0
70
24
42
78
663
1,279
800
689
256
1,475
1,159
1,984
3,300
2,356
2,046
1,525
1,310
1,626
1,760
1,564
3,158
2,531
4,562
2,846
2,8464,5622,5313,1581,5641,7601,6261,3101,5252,0462,3563,3001,9841,1591,4752566898001,279663784224700000
   > Long-term Liabilities 
0
0
0
0
0
1
8
45
77
371
864
48
72
4
7
0
3
2
0
0
1
35
42
48
74
123
52
89
89521237448423510023074724886437177458100000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
38
60
0
0
0
000603810000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
1
35
42
10
14
20
0
0
002014104235100200000000000000000
> Total Stockholder Equity
-1
-81
20,729
21,393
16,678
15,777
38,467
19,515
8,735
5,611
9,888
3,750
5,229
6,931
5,623
13,975
37,686
39,113
31,367
23,690
16,081
16,555
10,548
30,470
35,469
22,813
13,798
42,403
42,40313,79822,81335,46930,47010,54816,55516,08123,69031,36739,11337,68613,9755,6236,9315,2293,7509,8885,6118,73519,51538,46715,77716,67821,39320,729-81-1
   Common Stock
0
0
7,474
12,277
13,008
16,691
49,205
55,181
55,131
0
0
0
0
0
86,134
101,379
140,009
146,896
146,879
144,018
143,910
156,633
160,704
197,448
213,787
213,971
223,153
262,949
262,949223,153213,971213,787197,448160,704156,633143,910144,018146,879146,896140,009101,37986,1340000055,13155,18149,20516,69113,00812,2777,47400
   Retained Earnings Total Equity0000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-145
-230
14,573
14,602
-49,266
-52,472
6,081
-526
-330
9,495
9,633
10,527
8,937
9,363
9,363
2,320
1,754
1,159
866
2,751
3,566
3,972
4,806
5,342
5,3424,8063,9723,5662,7518661,1591,7542,3209,3639,3638,93710,5279,6339,495-330-5266,081-52,472-49,26614,60214,573-230-1450000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,363
0
0
0
0
0
0
0
0
0
0
00000000009,36300000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
-1
-81
13,255
9,116
14,814
14,848
0
0
107,236
110,566
70,005
7,127
75,120
82,341
86,134
0
0
12,065
12,065
2,320
1,754
1,159
-6,285
-27,720
-31,903
-18,840
0
0
00-18,840-31,903-27,720-6,2851,1591,7542,32012,06512,0650086,13482,34175,1207,12770,005110,566107,2360014,84814,8149,11613,255-81-1



5.3. Balance Sheets

Currency in AUD. All numbers in thousands.




5.4. Cash Flows

Currency in AUD. All numbers in thousands.




5.5. Income Statements

Currency in AUD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2025-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue5,439
Cost of Revenue-128
Gross Profit5,3115,311
 
Operating Income (+$)
Gross Profit5,311
Operating Expense-19,886
Operating Income-14,574-14,574
 
Operating Expense (+$)
Research Development14,404
Selling General Administrative5,481
Selling And Marketing Expenses-
Operating Expense19,88619,886
 
Net Interest Income (+$)
Interest Income446
Interest Expense--
Other Finance Cost-0
Net Interest Income446
 
Pretax Income (+$)
Operating Income-14,574
Net Interest Income446
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-12,080-17,069
EBIT - interestExpense = -14,662
-12,080
-12,148
Interest Expense-
Earnings Before Interest and Taxes (EBIT)-14,662-12,080
Earnings Before Interest and Taxes (EBITDA)-14,633
 
After tax Income (+$)
Income Before Tax-12,080
Tax Provision-68
Net Income From Continuing Ops-12,148-12,148
Net Income-12,148
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses20,013
Total Other Income/Expenses Net2,495-446
 

Technical Analysis of Alterity Therapeutics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alterity Therapeutics Ltd. The general trend of Alterity Therapeutics Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alterity Therapeutics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Alterity Therapeutics Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alterity Therapeutics Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.012 < 0.012 < 0.012.

The bearish price targets are: 0.011 > 0.011 > 0.009.

Know someone who trades $ATH? Share this with them.👇

Alterity Therapeutics Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alterity Therapeutics Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alterity Therapeutics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartAlterity Therapeutics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alterity Therapeutics Ltd. The current adx is .

Alterity Therapeutics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Relative Strength Index (RSI) ChartAlterity Therapeutics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Stochastic Oscillator ChartAlterity Therapeutics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Commodity Channel Index (CCI) ChartAlterity Therapeutics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) ChartAlterity Therapeutics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Williams %R ChartAlterity Therapeutics Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Average True Range (ATR) ChartAlterity Therapeutics Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily On-Balance Volume (OBV) ChartAlterity Therapeutics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd Daily Money Flow Index (MFI) ChartAlterity Therapeutics Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alterity Therapeutics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-06-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-14STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-08-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-09-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-10-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-10-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside

6.3. Candlestick Patterns

Alterity Therapeutics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alterity Therapeutics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.012
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Alterity Therapeutics Ltd with someone you think should read this too:
  • Are you bullish or bearish on Alterity Therapeutics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alterity Therapeutics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alterity Therapeutics Ltd

I send you an email if I find something interesting about Alterity Therapeutics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Alterity Therapeutics Ltd.

Receive notifications about Alterity Therapeutics Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.